Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.

Ítems similars

• Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.
  per: Mohamed, Ahmed A A, et al.
  Publicat: (2002)
• JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
  per: MacFarlane, M, et al.
  Publicat: (2000)
• c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases.
  per: Minden, A, et al.
  Publicat: (1994)
• MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson’s Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways
  per: Liu, Ying, et al.
  Publicat: (2017)
• Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors.
  per: Whitmarsh, A J, et al.
  Publicat: (1997)